Bcl-2 expression and apoptosis induction in human HL60 leukaemic cells treated with a novel organotellurium(IV) compound RT-04

Food and Chemical Toxicology

Volumn 46, Issue 7, 2008, Pages 2540-2545

  Abondanza, T S ^a   Oliveira, C R ^c   Barbosa, C M V ^a   Pereira, F E G ^a   Cunha, R L O R ^b   Caires, A C F ^a   Comasseto, J V ^b   Queiroz, M L S ^c   Valadares, M C ^d   Bincoletto, C ^c  

^a UNIVERSIDADE DE MOGI DAS CRUZES   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Apoptosis; Bcl 2 expression; Bone marrow; HL60; RT 04; Spleen

Indexed keywords

CASPASE 3; CASPASE 6; CASPASE 9; ORGANOTELLURIUM DERIVATIVE; PROTEIN BCL 2; TRYPAN BLUE;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BONE MARROW; CONTROLLED STUDY; DNA FRAGMENTATION; DOSE RESPONSE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IC 50; LEUKEMIA; LEUKEMIA CELL; MALE; MOUSE; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; HL-60 CELLS; HUMANS; INHIBITORY CONCENTRATION 50; MALE; MICE; ORGANOMETALLIC COMPOUNDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

MUS;

EID: 46549085190     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2008.04.010     Document Type: Article

References (37)

1. Alonso S., Minty A., Bourlet Y., and Buckingham M. Comparison of three actin-coding sequences in the mouse; evolutionary relationships between the actin genes of warm-blooded vertebrates. J. Mol. Evol. 23 (1986) 11-22
2. Baum C., Fairbairn L.J., Hildinger M., Lashford L.S., Hegewisch-Becker S., and Rafferty J.A. New perspectives for cancer chemotherapy by genetic protection of haematopoietic cells. Expert Rev. Mol. Med. 12 (1999) 1-28
3. Brito J.M., and Borojevic R. Liver granulomas in schistosomiasis: mast cell-dependent induction of SCF expression in hepatic satellite cells is mediated by TNF-alpha. J. Leuk. Biol. 62 (1997) 389-396
4. Cao G., Xiao M., Sun F., Xiao X., Pei W., Li J., Graham S.H., Simon R.P., and Chen J. Cloning of a novel Apaf-1-interacting protein: a potent suppressor of apoptosis and ischemic neuronal cell death. J. Neurosci. 24 (2004) 6189-6201
5. Chen F., Vallyathan V., Castranova V., and Shi X. Cell apoptosis induced by carcinogenic metals. Mol. Cell Biochem. 222 (2001) 183-188
6. Chen M., and Wang J. Initiator caspases in apoptosis signaling pathways. Apoptosis 4 (2002) 313-319
7. Cohen G.M. Caspases: the executioners of apoptosis. Biochem. J. 326 (1997) 1-16
8. Cunha R.L.O.R., Urano M.E., Chagas J.R., Almeida P.C., Bincoletto C., Tersariol I.L.S., and Comasseto J.V. Tellurium-based cysteine protease inhibitors: evaluation of novel organotellurium(IV) compounds as inhibitors of human cathepsin B. Bioorg. Med. Chem. Lett. 15 (2005) 755-760
9. Engman L., Al-Maharik N., McNaughton M., Birmingham A., and Powis G. Thioredoxin reductase and cancer cell growth inhibition by organotellurium compounds that could be selectively incorporated into tumor cells. Bioorg. Med. Chem. 11 (2003) 5091-5100
10. Fesik S.W. Promoting apoptosis as a strategy for cancer drugs discovery. Nat. Rev. 5 (2005) 876-885
11. Frei G.M., Lebenthal I., Albeck M., Albeck A., and Sredni B. Neutral and positively charged thiols synergize the effect of the immunomodulator AS101 as a growth inhibitor of Jurkat cells, by increasing its uptake. Biochem. Pharmacol. 74 (2007) 712-722
12. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
13. Harrison P.R., Lanfear J., Wu L., Fleming J., McGarry L., and Blower L. Chemopreventive and growth inhibitory effects of selenium. Biomed. Environ. Sci. 10 (1997) 235-245
14. Jiang X., and Wang X. Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1. J. Biol. Chem. 275 (2000) 31199-31203
15. Liu X., Zou H., Slaughter C., and Wang X. DFF a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89 (1997) 175-184
16. Lovschall H., Eiskjaer M., and Arenholt-Bindslev D. Formaldehyde cytotoxicity in three human cell types assessed in three different assays. Toxicol. In Vitro 16 (2002) 63-69
17. Malerba I., Casati S., Diodovich C., Parent-Massin D., and Gribaldo L. Inhibition of CFU-E/BFU-E and CFU-GM colony growth by cyclophosphamide, 5-fluorouracil and taxol: development of a high-throughput in vitro method. Toxicol. In Vitro 3 (2004) 293-300
18. McNaughton M., Engman L., Birmingham A., Powis G., and Cotgreave I.A. Cyclodextrin-derived diorganyl tellurides as glutathione peroxidase mimics and inhibitors of thioredoxin reductase and cancer cell growth. J. Med. Chem. 47 (2004) 233-239
19. Metcalf D. Clonal Culture of Hemopoietic Cells: Techniques and Applications (1984), Elsevier, Amsterdam p. 167
20. Minko T., Kopecková P., and Kopecek J. Preliminary evaluation of caspases-dependent apoptosis signaling pathways of free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells. J. Contr. Release 71 (2001) 227-237
21. Mosmmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Meth. 65 (1983) 55-63
22. Newell D.R., Silvester J., McDowell C., Burtles S.S., and Cancer Research UK. The Cancer Research UK experience of pre-clinical toxicology studies to support early clinical trials with novel cancer therapies. Eur. J. Cancer 40 (2004) 899-906
23. Noda Y., Suzuki T., Kahara A., Yotsuyanagi A., Hasegawa T., Hayshi M., Sofuni T., Yamanaka K., and Okada S. In vivo genotoxicity evaluation of dimethylarsinic in Muat™ mouse. Mut. Ras. Gen Toxicol. Muagen. 513 (2002) 205-212
24. Nogueira C.W., Zeni G., and Rocha J.B. Organoselenium and organotellurium compounds: toxicology and pharmacology. Chem. Rev. 104 (2004) 6255-6285
25. Oltersdorf T., Elmore S.W., Shoemaker A.R., et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435 (2005) 677-681
26. Osorio L.M., De Santiago A., Aguilar-Santelises M., Mellstedt H., and Jondal M. CD6 ligation modulates Bcl-2/Bax ratio and protects chronic lymphocytic leukemia B cells from apoptosis induced by anti-IgM. Blood 89 (1997) 2833-2841
27. Pailard F., Finot F., Mouche I., Perez A., and Vericat J.A. Use of primary cultures of rat hepatocytes to predict toxicity in the early development of new chemical entities. Toxicol. In vitro 13 (1999) 693-700
28. Parent-Massin D. Relevance of clonogenic assays in hematotoxicology. Cell Biol. Toxicol. 17 (2001) 87-94
29. Pessina A., Albella B., Bayo M., et al. Application of the CFU-GM assay to predict acute drug-induced neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics. Toxicol. Sci. 75 (2003) 355-367
30. Rinehart J., Adjei A.A., and Lorusso P.M. Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer. J. Clin. Oncol. 22 (2004) 4456-4462
31. Rodriguez J., and Lazebnik Y. Caspase-9 and APAF-1 form an active holoenzyme. Genes Dev. 13 (1999) 3179-3184
32. Sailer B.L., Liles N., Dickerson S., Sumners S., and Chasteen T.G. Oraganotellurium compound toxicity in a promyelocytic cell line compared to non-tellurium-containing organic analog. Toxicol. In vitro 18 (2004) 475-482
33. Stewart M.S., Davis R.L., Walsh L.P., and Pence B.C. Induction of differentiation and apoptosis by sodium selenite in human colonic carcinoma cells (HT29). Cancer Lett. 117 (1997) 35-40
34. Wei M.C., Zong W.X., Cheng E.H., et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292 (2001) 727-730
35. Wieslander E., Engman L., Svensjö E., et al. Antioxidative properties of organotellurium compounds in cell systems. Biochem. Pharmacol. 55 (1998) 573-584
36. Zeni G., Chieffi A., Cunha R.L.O.R., Stefani H.A., Zukerman-Schpector J., and Comasseto J.V. Organometallics 18 (1999) 803-806
37. Zimmermann K.C., Bonzon C., and Green D.R. The machinery of programmed cell death. Pharmacol. Ther. 92 (2001) 57-70